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As more states legalize marijuana, the potential of marijuana abuse could lead to an increase in the 
number of emergency department (ED) visits. We describe two patients who presented to the ED 
with dilated pupils, rigidity in both lower extremities, and clonus in both feet after inhaling the vapor 
of a highly potent form of marijuana. Serotonin syndrome diagnosis was initially considered in the 
differential diagnosis. Ultimately, high-potency marijuana abuse was the final diagnosis. Therefore, 
marijuana toxicity should be considered in ED patients who present with signs and symptoms similar to 
that of serotonin syndrome. [Clin Pract Cases Emerg Med.2020;4(2):X–X.]   
INTRODUCTION 
As the legalization of cannabis becomes prevalent in the 
United States, effects from its abuse will result in an increase 
in emergency department (ED) visits.1 We have witnessed 
a growing trend in our community ED among adolescents 
abusing a highly potent form of marijuana, butane hash oil 
(BHO). BHO is a concentrated form of tetrahydrocannabinol 
(THC) that is created by using liquid butane as a solvent 
to extract THC from marijuana plants. As butane is highly 
flammable, reports of burns and explosions have been reported 
from the synthesis and use of BHO. A popular trend called 
“dabbing” involves heating the concentrated oil and inhaling the 
resultant vapors. These vapors contain very high concentrations 
of THC, as high as 90% pure. Adolescents may use e-cigarette 
devices to abuse BHO as a delivery device. Such devices are 
easily concealed and produce almost no odor, thus leading to 
the potential for abuse at school and in the home.2,3
Previous case reports have shown BHO abuse may lead 
to agitation along with neurotoxicity and cardiotoxicity.3,4 
Since THC may activate serotonin receptors and inhibit 
serotonin reuptake, its abuse in high concentrations may 
mimic serotonin syndrome.5  We present two cases of 
adolescents with recent “dabbing” use who exhibited signs 
and symptoms of serotonin syndrome.
CASE REPORT
Case 1 
A 17-year-old female presented to a large community 
ED by emergency medical services (EMS) from her home for 
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*
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a possible seizure. EMS providers had witnessed agitation, 
altered mental status, tachycardia, muscle stiffness and 
tremors in the limbs, and administered 10 milligrams (mg) of 
midazolam intranasally. History was obtained from the EMS 
providers and the patient’s parents who were present in the 
room. The patient had been taking sertraline 50 mg daily and 
had also been prescribed a short course of cyclobenzaprine 
5 mg every eight hours, as needed, for “muscle aches.”  
According to the parents, the patient had taken “a few” but 
stopped the cyclobenzaprine as it was not effective. No history 
of drug overdose or recent illness was obtained. 
Upon arrival to the ED, the patient was obtunded (likely 
secondary to benzodiazepine), but would occasionally follow 
commands. Her Glasgow Coma Score was eight, scoring two 
points for eye-opening response, two points for verbal response, 
and four points for motor response. Vital signs revealed blood 
pressure of 135/81 millimeters of mercury (mmHg), pulse 124 
beats per minute (bpm), rectal temperature of 99.6 degrees 
Fahrenheit (F), and 97% pulse oximetry on room air. Physical 
exam revealed dilated pupils of six millimeters (mm), normal 
neck exam, normal lung sounds, a soft and non-tender abdomen, 
and normal heart sounds. A neurological exam revealed rigidity 
in both lower extremities with a sparing of rigidity in the arms. 
Deep tendon reflexes showed sustained clonus in both feet, and 
the presence of hyper-reflexivity in the patella tendons bilaterally 
but with normal reflexes in the upper extremities. 
Lab results showed a normal complete blood count, 
normal creatine kinase, normal comprehensive metabolic 
profile, normal arterial blood gas, normal prolactin level, 
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What do we already know about this clinical 
entity? 
Serotonin syndrome and marijuana abuse are 
recognizable conditions encountered in the practice 
of emergency medicine. 
What makes this presentation of disease reportable? 
We report two cases of high-potency marijuana abuse 
that mimicked serotonin syndrome. 
What is the major learning point? 
When encountering potential serotonin syndrome, 
a thorough social history and drug testing may be 
needed to rule out a disease mimic.
How might this improve emergency medicine 
practice? 
As legalized marijuana becomes more prevalent, 
emergency physicians should be aware of this 
disease mimic.
and a urine drug screen positive for THC. Electrocardiogram 
showed sinus tachycardia, and a non-contrasted head 
computed tomography was normal. Serotonin syndrome 
was considered in the differential diagnosis. After pediatric 
critical care and pediatric neurology consultation, one 
oral dose of cyprohepatidine 4 mg was administered. The 
patient was admitted to the pediatric intensive care unit. 
Magnetic resonance imaging of the brain was normal, and 
an electroencephalogram showed no epileptic activity. The 
patient rapidly improved and was discharged the following 
day. Prior to discharge, the patient admitted to “dabbing” 
about 30 minutes prior to arrival to the hospital.  The same 
patient returned to the ED the following night with a similar 
presentation, once again associated with dabbing. 
Case 2
 A 16-year-old male took “a hit from a dab pen” while 
on the bus to school. He developed altered mental status and 
was transported to the ED. On arrival he was mildly obtunded, 
Glasgow Coma Score was 13 (three for eye-opening response, 
four verbal response, and six motor response). Vital signs were 
recorded as blood pressure 152/86 mmHg, pulse 116 bpm, oral 
temperature 98.6° F and 100% pulse oximetry on room air. 
Physical exam showed dilated pupils to five mm, tachycardia, and 
rigidity of the lower extremities with non-sustained clonus in the 
legs bilaterally. Lab results were normal with the exception of a 
drug screen positive for THC. This patient slowly improved over 
six hours of observation in the ED and was discharged home.
DISCUSSION 
Psychotic states, cardiac toxicity, and neurotoxicity have 
been reported as clinical sequelae of THC-induced toxicity.4,6 
Our cases show additional harmful side effects of highly 
concentrated THC when abused by adolescents in its vapor, 
or “dabbing” form. Although the cases did not show all of the 
hallmarks of a true serotonin syndrome, some overlap existed 
in physical exam findings. Serotonin syndrome may show 
vital sign abnormalities such as tachycardia, hypertension, and 
hyperthermia. Physical exam findings of serotonin syndrome 
may reveal agitation, ocular clonus, dilated pupils, tremor, deep 
tendon hyper-reflexia, muscle clonus, dry mucus membranes, 
and flushed skin with diaphoresis.7 
The most striking exam finding in these two ED patients was 
the lower extremity rigidity with hyper-reflexivity. Animal studies 
have demonstrated that potent cannabinoid receptor agonists 
may activate the serotonin receptors (5-hydroxytryptamine1A and 
5-hydroxytryptamine2A), and THC inhibits serotonin re-uptake.
5, 8 
Therefore, it is likely that emergency physicians may see some of 
the hallmarks of serotonin syndrome in “dabbing” users.
CONCLUSION 
Medical marijuana and cannabidiol have been used 
and proved to be medically safe and effective; however, as 
marijuana use grows there is increased access of cannabinol 
products, including high-concentrate THCs. Our cases reflect 
that adolescents who abuse THC by heating and then inhaling 
the concentrated vapor, can present with signs and symptoms 
that mimic serotonin syndrome. For that reason, high-potency 
marijuana abuse should be considered when encountering young 
adults in the ED with these exam findings.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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